These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 831951)

  • 1. A report on the use of Arvin in patients with pre-gangrene of the lower limb.
    Humphreys WV; Walker A; Charlesworth D
    Br J Surg; 1977 Jan; 64(1):31-3. PubMed ID: 831951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arvin in the treatment of advanced atherosclerosis. Preliminary report].
    Kroese AJ
    Tidsskr Nor Laegeforen; 1976 Apr; 96(12):700-1. PubMed ID: 936123
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of thrombosis by sequential therapy with ancrod followed by streptokinase. Clinical pharmacology and rheology.
    Forbes CD; Barbenell J; Prentice CR
    Haemostasis; 1976; 5(6):348-54. PubMed ID: 1017726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA; Goyle KB
    Br J Surg; 1976 Aug; 63(8):661-2. PubMed ID: 953495
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of severe intermittent claudication by controlled defibrination.
    Dormandy JA; Goyle KB; Reid HL
    Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation studies during therapeutic application of arvin.
    Vinazzer H
    Thromb Res; 1976 Feb; 8(2):243-8. PubMed ID: 943132
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous ancrod after operation for fractured hip--a dose-ranging and feasibility study.
    Lowe GD; Morrice JJ; Fulton A; Forbes CD; Prentice CR; Barbenel JC
    Thromb Haemost; 1978 Aug; 40(1):134-43. PubMed ID: 725844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of the sequential use of streptokinase and ancrod in the treatment of deep vein thrombosis of lower limb.
    Tibbutt DA; Chesterman CN; Williams EW; Faulkner T; Sharp AA
    Thromb Haemost; 1977 Apr; 37(2):222-32. PubMed ID: 577626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind controlled clinical trial of ancrod for ischemic rest pain of the leg.
    Lowe GD; Dunlop DJ; Lawson DH; Pollock JG; Watt JK; Forbes CD; Prentice CR; Drummond MM
    Angiology; 1982 Jan; 33(1):46-50. PubMed ID: 7036801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of experimental postoperative adhesions by ancrod defibrinogenation.
    Buckman RF; Bordos D; Bell WR; Cameron JL
    J Surg Res; 1975 Apr; 18(4):377-84. PubMed ID: 1142753
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple courses of ancrod (Arvin) therapy.
    Kounis NG; Evans WH
    Br Med J; 1977 Jan; 1(6056):290-1. PubMed ID: 837082
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of Arvin and surgery on red cell filterability.
    Ernst E; Dormandy J
    Scand J Clin Lab Invest Suppl; 1981; 156():317-9. PubMed ID: 6948396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
    Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Grzegorczyn S
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):700-3. PubMed ID: 1669136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo production of soluble complexes containing fibrinogen-fibrin related antigen during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Thromb Res; 1975 Sep; 7(3):361-72. PubMed ID: 1188838
    [No Abstract]   [Full Text] [Related]  

  • 18. Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
    Wolf GK
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):387-92. PubMed ID: 786664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defibrinogenation by Arvin reduces air-drying-induced arteriosclerosis in rat carotid artery.
    van Pelt-Verkuil E; van de Ree P; Emeis JJ
    Thromb Haemost; 1989 Apr; 61(2):246-9. PubMed ID: 2749599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorheological aspects of the Arvin therapy of acute thromboses of the magistral veins of the lower extremities].
    Aleksandrova NP; Leont'ev SG; Karalkin AV; Berezov VP
    Grud Serdechnososudistaia Khir; 1990 Dec; (12):15-8. PubMed ID: 2078376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.